DistantNews
Support us
🇳🇬 Nigeria /Crime & Justice

NAFDAC Confirms Deleject Syringes Safe After Investigation

From ThisDay · () English

Translated from English, summarized and contextualized by DistantNews.

At a glance

News Named sources Outcome reported
  • NAFDAC has declared Deleject Disposable Needles safe for use after an investigation into a complaint about particulate matter.
  • The agency stated that the specific batch in question was likely compromised during transportation, storage, or distribution, not due to a manufacturing defect.
  • NAFDAC urged distributors to ensure proper handling and storage of medical products and clarified an earlier public alert was published in error.

The National Agency for Food and Drug Administration and Control (NAFDAC) has confirmed that Deleject Disposable Needles are safe for use, following an investigation into a complaint alleging particulate matter in a specific batch. The agency concluded that there is no evidence of a manufacturing defect or safety risk associated with the products currently in circulation.

Yes, the complaint came from a pharmacy called Jiyah, and Jiyah told us that he purchased that product from Zagbayi. We went to Zagbayi, and Zagbayi said yes, he was supplied by the company. But going back to the facility where this was produced, all the procedures, all the steps were followed, all root-cause analyses were done, and we couldn’t place any error coming from that site.

— Bitrus FradenExplaining the findings of NAFDAC's investigation into the Deleject syringes.

NAFDAC's investigation, prompted by a complaint from a pharmacist in Kaduna, focused on Batch No. 240605. The agency traced the product through the distribution chain to the manufacturer, HMA. Investigations at the manufacturing facility found that all procedures were followed, and root-cause analysis revealed no misconduct or non-conformity with Good Manufacturing Practice (GMP) requirements. NAFDAC clarified that an earlier Public Alert on the batch was published on its website in error and should be disregarded.

Bitrus Fraden, Director of Post Marketing Surveillance at NAFDAC, explained that the complaint likely stemmed from improper handling. "The particular Delegect Disposable Needle batch being complained about may have been compromised or improperly handled during transportation, storage or distribution," he stated. NAFDAC conducted nationwide surveillance following the complaint but found no similar reports from other parts of the country, indicating the issue was isolated.

A nationwide surveillance was conducted on this same product, and we discovered it was not widespread. It was just that incident that happened in Kaduna.

— Bitrus FradenDescribing the results of NAFDAC's nationwide checks.

The agency urged distributors of drugs and other medical products to ensure proper transportation and storage conditions. Fraden emphasized NAFDAC's commitment to caution, stating, "It is better for us to act on the side of caution than to allow that to go on to affect lives." The affected products from the distributor and pharmacy were reportedly removed after the complaint was lodged.

It is better for us to act on the side of caution than to allow that to go on to affect lives.

— Bitrus FradenHighlighting NAFDAC's approach to product safety.
DistantNews Editorial

Originally published by ThisDay in English. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.

More Stories

From Our Blog